Locations:
SearchAdvertisement
Improvements enable targeting of brain tumors with single-session, fractionated or neoadjuvant approaches
New review published in Cancers suggests a synergistic benefit
This approach led to local control for patients with brain metastases more than 2 cm in diameter
We now have an expanded toolbox to extend survival and lessen treatment toxicity
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Two stereotactic radiosurgery experts take stock after Cleveland Clinic’s 10,000th case
Study presented at ASTRO 2021 shows promise in patients treated with stereotactic radiosurgery
Why it remains the mainstay for newly diagnosed metastases and tumors
Number of brain metastases doesn’t matter for ALK/EGFR+ patients
A neurosurgeon and a neuro-oncologist recap recent and emerging advances
Dose-escalation trial shows local control with low toxicity, low leptomeningeal recurrence
Advertisement
Advertisement